<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82812">
  <stage>Registered</stage>
  <submitdate>9/05/2008</submitdate>
  <approvaldate>8/05/2009</approvaldate>
  <actrnumber>ACTRN12609000229279</actrnumber>
  <trial_identification>
    <studytitle>Randomized controlled trial of cognitive behaviour therapy to reduce symptoms of complicated grief caused by the loss of a loved one</studytitle>
    <scientifictitle>Randomized controlled trial of cognitive behaviour therapy to reduce symptoms of complicated grief caused by the loss of a loved one</scientifictitle>
    <utrn />
    <trialacronym>Treating complicated grief</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Complicated grief</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Depression</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cognitive behaviour therapy involves 10 90-minute sessions of group therapy and 4 60-minute sessions of individual therapy over a 10-week period; the 4 individual sessions occur in weeks-3-6 of the treatment program.  The therapy includes discussing memories of the deceased, re-appraising beliefs about the loss, and learning activity schedules.</interventions>
    <comparator>Modified cognitive behaviour therapy involves 10 sessions of group therapy and 4 sessions of individual therapy over a 10-week period; the 4 individual sessions occur in weeks-3-6 of the treatment program.  Modified cognitive behaviour therapy comprises re-appraising beliefs about the loss, and learning activity schedules.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Complicated grief, defined as severe grief reactions that persist beyond 6 months after the death of a loved one, and measured by the Inventory of Complicated Grief</outcome>
      <timepoint>Administered pretreatment, posttreatment, and 6 months follow-up.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Posttraumatic stress disorder measured by the Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale.</outcome>
      <timepoint>Administered pretreatment, posttreatment, and 6 months follow-up.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Depression assessed by the Beck Depression Inventory</outcome>
      <timepoint>Administered pretreatment, posttreatment, and 6 months follow-up.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(a) Loss of loved one, (b) Meet criteria for complicated grief, (c) at least 6 months duration</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Psychosis, substance dependent, suicidal intent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants were randomly assigned according to a random numbers system administered by an individual who was independent of the study and who worked at a site that was distant from the treatment center.</concealment>
    <sequence>Randomization was conducted by a process of minimization stratified on gender, grief type, and grief total score.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>90</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of New South Wales</primarysponsorname>
    <primarysponsoraddress>University of New South Wales
Sydney, NSW, 2052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health &amp; Medical Research Council</fundingname>
      <fundingaddress>GPO Box 1421 Canberra ACT  2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Westmead Hospital</sponsorname>
      <sponsoraddress>Westmead Hospital
O'Briens Rd
Westmead, NSW, 2145</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patients with complicated grief will be randomly allcoated to a combiantion of group and individual therapy.  Patients will receive either 10 sessions of cognitive behaviour therapy with exposure therapy, cognitive behaviour therapy without exposure therapy, or skills training.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of New South Wales Human Ethics Committee</ethicname>
      <ethicaddress>University of New South Wales
Sydney, NSW, 2052</ethicaddress>
      <ethicapprovaldate>5/03/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney,  NSW, 2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney,  NSW, 2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Richard Bryant</name>
      <address>School of Psychology
University of New South Wales
Sydney,  NSW, 2052</address>
      <phone>61-2-93853640</phone>
      <fax>61-2-93853641</fax>
      <email>r.bryant@unsw.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>